PCI president Montu Patel loses Gujarat state pharmacy council membership

Ahmedabad: The Health and Family Welfare Department has removed Montu Kumar Patel from the Gujarat State Pharmacy Council, raising questions about his continuation as president of the Pharmacy Council of India (PCI). The action follows a July 23 order from the administration of Daman & Diu and Dadra & Nagar Haveli, which cancelled Patel’s nomination and removed him from the council.

According to Medical Dialogues reports, the notification issued by the department serves as the first step in the process to remove Patel from his position as PCI president by cancelling his primary membership in the Gujarat State Pharmacy Council. The department’s action formally initiates administrative proceedings that may affect his current role at the national council.

Patel, elected PCI president in 2022, was also serving as the president of the Gujarat State Pharmacy Council. In July, he came under investigation by the Central Bureau of Investigation (CBI) after raids were conducted at his residence in Ahmedabad.

The CBI probe concerns allegations that Patel granted approvals to pharmacy colleges in exchange for bribes, manipulated inspection procedures, and issued irregular recognitions to institutions.

Documents and financial records were seized during the raids, and the investigation has been expanded to other states. Medical Dialogues reported that these developments have increased scrutiny of PCI’s operations.

SC notes procedural lapses by PCI

The removal of Patel follows earlier criticism of PCI. In May, the Supreme Court had noted that the council rejected pharmacy college approvals without following due process and directed adherence to prescribed guidelines.

The developments coincide with ongoing discussions on reforms in pharmacy education regulation, including approval procedures, inspections, and recognition issuance.

According to DeshGujarat, the Health and Family Welfare Department has formally started the procedure to remove Patel as PCI president by cancelling his primary membership in the Gujarat State Pharmacy Council. These administrative and legal steps indicate that PCI leadership may change as investigations and review of council processes continue.

Related Posts

Mankind Pharma to Acquire 70% Stake in Belgium’s ACTx

Shares of Mankind Pharma fell more than 2% on 16 October after the company announced that it has signed an agreement to acquire a 70% stake in Belgium-based biotechnology company…

Can a drug licence be suspended before a hearing? Karnataka HC explains rule

NEW DELHI: Can a drug licensing authority suspend a pharmaceutical distributor’s licence while issuing a show-cause notice, before considering its response? The Karnataka high court has said the procedure under…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Mankind Pharma to Acquire 70% Stake in Belgium’s ACTx

Mankind Pharma to Acquire 70% Stake in Belgium’s ACTx

Can a drug licence be suspended before a hearing? Karnataka HC explains rule

Can a drug licence be suspended before a hearing? Karnataka HC explains rule

A Boy survives 18th Floor Fall, thanks to Yashoda Medicity

A Boy survives 18th Floor Fall, thanks to Yashoda Medicity

AstraZeneca, NIPER Raebareli partner to upgrade 25 clinical trail sites

AstraZeneca, NIPER Raebareli partner to upgrade 25 clinical trail sites

FDA clears ImmunityBio’s Anktiva expansion in bladder cancer after regulatory whiplash

FDA clears ImmunityBio’s Anktiva expansion in bladder cancer after regulatory whiplash

Sun Pharma Approves Rs 10,000 Crore Fundraising Through NCDs

Sun Pharma Approves Rs 10,000 Crore Fundraising Through NCDs